Image: Bank Vault (© Corbis/Corbis)
Up next: Biggest bank IPO ever

It's no Alibaba, but the Citizens Financial Group offering is important to the market.


The company has successfully deployed its strategy of targeting commercial airplanes as its major future growth driver.

By Trefis Mar 8, 2012 5:56PM
Boeing (BA), one of the biggest aircraft makers in the world, recently celebrated the completion of its 1,000th 777 jetliner. The aircraft will be delivered to Dubai based Emirates Airways later this month.

This is a significant milestone for the company, making 777 the fastest twin-aisle airplane ever to reach this mark. It also validates Boeing's strategy to target commercial airplanes as its major growth driver in coming years. Commercial airplanes are the most valuable division at Boeing, accounting for nearly 53% of the stock's value. 
Tags: BA

Suddenly there's a very good reason why the company is holding on to its mountains of cash.

By Jim J. Jubak Mar 8, 2012 5:45PM
Credit: © Tony Avelar/Bloomberg via Getty Images
Caption: Apple Unveils Updated iPadBy now every techno-geek in the known universe has weighed in on what everyone but Apple (AAPL) calls the iPad 3. The general impression I get from reading the comments is the rather typical wish that Apple had done more. 

The quad-core processor isn't as fast as the one on the iPhone. Apple didn't significantly reduce the weight of the new iPad. The form looks the same as the current iPad. There's even the wishful longing for Siri to talk to.

Johnson & Johnson's recently approved Zytiga continues to score at the expense of Dendreon's Provenge.

By Melly Alazraki Mar 8, 2012 4:22PM

Johnson & Johnson's (JNJ) recently approved prostate cancer drug Zytiga continues to impress. On Thursday, the company said the drug improved survival and delayed the progression of cancer in patients with less advanced disease, according to a late-stage study.


For now, the drug is approved only for treatment in men with a late-stage form of prostate cancer who have failed to respond to chemotherapy. But the study was in men with earlier stages of the disease and who had not been treated with chemotherapy. Approval to treat this new prospective patient population could significantly grow the drug's market.


The Iraqi government is unhappy with the independent deal Exxon struck with Kurdistan to explore for oil.

By Trefis Mar 8, 2012 4:04PM
Image: Oil derricks (© Comstock/Corbis)Exxon Mobil (XOM) wants to explore for oil in Iraq's Kurdistan region, and last year signed a deal with the Kurdistan government to begin the process. But the idea has infuriated Baghdad, creating a political wrinkle the company still hasn't ironed out.

The Iraqi government refuses to recognize deals that foreign oil majors strike with Kurdistan, and Iraq has pressured Exxon to drop the agreement it signed. It's now waiting for an answer, and then will decide whether Exxon should be allowed to bid in its next round of oil exploration licenses. 

Two law professors think the government should regulate new financial products as closely as it monitors new drugs.

By Kim Peterson Mar 8, 2012 3:26PM
Image: Spy (© Corbis)Here's an idea Wall Street will completely despise. Two University of Chicago law professors think the government should clamp down on new financial products with the same scrutiny it applies to new drugs.

When Wall Street whizzes come up with new derivatives or other products, they shouldn't be allowed to market them until the government approves, write Eric Posner and E. Glen Weyl in a recent paper. The government should have an agency similar to the Food and Drug Administration that screens financial proposals carefully. 

Volume patterns suggest these stocks are good buys for yield- and safety-oriented buyers.

By Mar 8, 2012 3:12PM

Image: Natural gas plant (© Kevin Burke/Corbis)By Tom Aspray

As I noted in January, seasonal analysis indicates that the Select Sector SPDR - Utilities (XLU) "typically tops in late December and bottoms in March." There were also technical signs at the end of 2011 that the best-performing sector in 2011 (up 14.8%) was forming a short-term top.

Even though XLU is down just under 3% in 2012, individual utilities like Dominion Resources (D), which is the ETF's second-largest holding, is down 4.9%. Dominion pays an annual dividend of $2.11, and at the end of 2011, it was yielding 4.02%. Following the correction, it now yields 4.20%.

Tags: DNFG

A study finds patients using a single pharmacy are more likely to connect with pharmacists.

By Mar 8, 2012 2:49PM

Image: Pills (© Digital Vision Ltd./SuperStock/SuperStock)By Zacks Equity Research

Recently, CVS Caremark (CVS) joined Harvard University and Brigham and Women's Hospital in an extensive study on health policy. 

They came up with some new ways to save money while being treated. One of their findings was the importance of a single "pharmacy home" for pharmacy customers.


Casino stocks have been on fire the past 2 years, and January's gaming numbers show the momentum isn't slowing.

By Kim Peterson Mar 8, 2012 2:34PM
Image: Gambling (© Corbis)Las Vegas is no longer down on its luck.

Gambling revenue in Nevada rose nearly 18.4% in January to nearly $1.04 billion. It was the first $1 billion month for the state in more than three years, according to the Las Vegas Review-Journal.

Some of the increase had to do with the Chinese New Year holiday taking place in January this year instead of February. Las Vegas is among the top 10 places to visit for Chinese New Year, according to a recent report, and the city works hard to lure visitors from mainland China for the celebration. 

Brewer aims to make Budweiser the undisputed 'King of Beers.'

By Jonathan Berr Mar 8, 2012 2:25PM
Image: Beer (© Corbis)Before InBev NV bought Anheuser-Busch Cos. in 2008 in for $52 billion, 28% of Budweiser's sales came from outside the U.S. The figure now is 44% as Anheuser Busch InBev (BUD) tries to make Budweiser the "first truly" global beer brand to make up for slumping sales in its home market. 

Success is not a given.
Tags: BUD

These 3 stocks meet the criteria of the pioneer of value investing.

By TheStockAdvisors Mar 8, 2012 1:29PM
By J. Royden Ward, Cabot Benjamin Graham Value Letter

Since its inception nine years ago, our Classic Value Model portfolio has achieved a total return, not including dividends, of 190.2%. Compare that to just 46.2% for the Dow industrials.

Here's a look at three additions to this portfolio that reflect the criteria of value investment guru Ben Graham: Silver Wheaton (SLW), WellPoint (WLP) and Templeton Global Income Fund (GIM).

The new iteration of the iPad will only drive the stock higher as owners upgrade, passing their old models on to their children.

By Jim Cramer Mar 8, 2012 1:20PM

Will people buy Apple's (AAPL) iPad 3, and will sales be good enough to propel the stock even higher? Talk about a half-a-trillion-dollar question.


I think they will because we are headed into a world where there's a chicken in every pot and an iPad in the hands of every man, woman and child.


The company plans to sell the Verismo this fall, and says it will maintain a relationship with Green Mountain Coffee Roasters.

By Kim Peterson Mar 8, 2012 12:55PM
Credit: © 2012 Starbucks Corporation
Caption: Verismo® System by Starbucks, A New Premium Single Cup Solution for At-Home Espresso and Coffee BeveragesUpdated 5:35 p.m. ET

(SBUX) is jumping into the single-cup brewing market, preparing to launch a home-based machine called Verismo.

The machine (pictured) is slated to launch this fall at specialty stores, at some Starbucks cafes and online. It's a direct hit at the single-cup brewers made popular by Green Mountain Coffee Roasters (GMCR).

In a webcast Thursday afternoon, CEO Howard Schultz said Verismo will differ from Green Mountain's Keurig machines. 

Williams-Sonoma is downgraded to 'underperform,' and Angie's List is initiated with a 'buy.'

By MSN Money Partner Mar 8, 2012 12:02PM
Information provided by

Thursday's noteworthy upgrades include:
  • ARM Holdings (ARMH) upgraded to Overweight from Equal Weight at Morgan Stanley
  • American Eagle (AEO) upgraded to Conviction Buy from Buy at Goldman, and to Buy from Neutral at Nomura
  • Macerich (MAC) upgraded to Buy from Hold at Jefferies

Forget about Facebook. The manufacturer of the iconic Stratocaster is making noise with plans to go public.

By InvestorPlace Mar 8, 2012 11:47AM
Image: Fender guitar (© Corbis)By Tom Taulli

Leo Fender, the founder of the Fender Musical Instruments Corp., brought to life the Telecaster, the first commercially successful solid-body electric guitar. It would help make Fender an iconic brand for the rock 'n' roll movement and bring the guitar brand into the pop culture mainstream.

Now Fender is aiming for the U.S. market mainstream via a stock IPO.


Burger chain's results are still outstanding.

By Jonathan Berr Mar 8, 2012 11:46AM

Photodisc/SuperStockMcDonald's (MCD) shares are down over 3% in early trading after the company reminded investors it was not immune to the world's economic pressures. The burger chain results were otherwise outstanding.

Comparable sales in the U.S. rose 11.1% in February, fueled by strong demand for Chicken McBites, Filet-O-Fish, coffee beverages and McDonald's breakfast line-up. Sales at stores opened for at least a year rose 4% in Europe, led by gains in the U.K. and Russia. And strength in Australia boosted sales in Asia/Pacific, Middle East and Africa by 2.4%. Systemwide sales for February jumped 9.4%, or 9.7% in constant currencies, helped by the extra day in the month because of leap year.

Tags: MCD


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

123 rated 1
262 rated 2
480 rated 3
651 rated 4
649 rated 5
629 rated 6
616 rated 7
496 rated 8
346 rated 9
111 rated 10

Top Picks

TAT&T Inc9

Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market finished an upbeat week on a mixed note. The S&P 500 shed less than a point, ending the week higher by 1.3%, while the Dow Jones Industrial Average (+0.1%) cemented a 1.7% advance for the week. High-beta names underperformed, which weighed on the Nasdaq Composite (-0.3%) and the Russell 2000 (-1.3%).

Equity indices displayed strength in the early going with the S&P 500 tagging the 2,019 level during the opening 30 minutes of the action. However, ... More


There’s a problem getting this information right now. Please try again later.